Paper8915035
The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group.
Rogers SL and 1 other. Dementia, 1996. Cited by 651 papers, by iCite.
Cite this record
ConductScience Library. The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group. Papers, record 8915035. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8915035
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group.
- PubMed
- Publication types
- Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Cholinesterase Inhibitors | Major topic |
| Indans | Major topic |
| Piperidines | Major topic |
| Acetylcholinesterase | |
| Aged | |
| Cognition | |
| Donepezil | |
| Double-Blind Method | |
| Erythrocytes | |
| Female | |
| Humans | |
| Male | |
| Mental Health | |
| Middle Aged | |
| Osmolar Concentration | |
| Placebos |
Source PubMed
Cited by179
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 651 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41966601 | Comparative effects of some pharmacological and non-pharmacological interventions on cognitive function in Alzheimer's disease: A Bayesian network meta-analysis. | J Prev Alzheimers Dis | 2026 | https://conductscience.org/library/papers/41966601 | PubMed |
| 41847148 | Nanotechnology-based targeted delivery strategies for the treatment of Alzheimer's disease. | Nanoscale Adv | 2026 | https://conductscience.org/library/papers/41847148 | PubMed |
| 41227148 | Alzheimer Syndrome or Age-Related Dementia-History, Therapy and Prevention. | J Clin Med | 2025 | https://conductscience.org/library/papers/41227148 | PubMed |
| 40938363 | Molecular mechanisms underlying cyclophosphamide-induced ovarian injury and protective strategies. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/40938363 | PubMed |
| 40860505 | Efficacy of medications in controlling cognitive dysfunction in Alzheimer's : a systematic review. | Dement Neuropsychol | 2025 | https://conductscience.org/library/papers/40860505 | PubMed |
| 40463338 | Innovative sensors with selectivity enhancement by molecularly imprinted polymers for the concurrent quantification of donepezil and memantine. | RSC Adv | 2025 | https://conductscience.org/library/papers/40463338 | PubMed |
| 40034344 | Therapeutic drug monitoring for dose optimization in Alzheimer's disease and in dementia with Lewy bodies: A randomized single-blinded clinical trial. | J Alzheimers Dis Rep | 2024 | https://conductscience.org/library/papers/40034344 | PubMed |
| 39966707 | Type 3 diabetes and metabolic reprogramming of brain neurons: causes and therapeutic strategies. | Mol Med | 2025 | https://conductscience.org/library/papers/39966707 | PubMed |
| 39748300 | Estimating undiagnosed dementia in England using capture recapture techniques. | BMC Geriatr | 2025 | https://conductscience.org/library/papers/39748300 | PubMed |
| 38974438 | Does Vascular Dementia Exist? Report of Two Cases Previously Diagnosed with Vascular Dementia Treated by Means of Ventriculoatrial Shunts. | Asian J Neurosurg | 2024 | https://conductscience.org/library/papers/38974438 | PubMed |
| 38389390 | Shortening the Alzheimer's disease assessment scale cognitive subscale. | Eur Psychiatry | 2024 | https://conductscience.org/library/papers/38389390 | PubMed |
| 38256670 | Controversial Past, Splendid Present, Unpredictable Future: A Brief Review of Alzheimer Disease History. | J Clin Med | 2024 | https://conductscience.org/library/papers/38256670 | PubMed |
| 37341896 | Turning the Spotlight to Cholinergic Pharmacotherapy of the Human Language System. | CNS Drugs | 2023 | https://conductscience.org/library/papers/37341896 | PubMed |
| 37212107 | miRNAs and Stem Cells as Promising Diagnostic and Therapeutic Targets for Alzheimer's Disease. | J Alzheimers Dis | 2023 | https://conductscience.org/library/papers/37212107 | PubMed |
| 37086935 | New perspectives on the basal forebrain cholinergic system in Alzheimer's disease. | Neurosci Biobehav Rev | 2023 | https://conductscience.org/library/papers/37086935 | PubMed |
| 36986776 | Photobiomodulation in Alzheimer's Disease-A Complementary Method to State-of-the-Art Pharmaceutical Formulations and Nanomedicine? | Pharmaceutics | 2023 | https://conductscience.org/library/papers/36986776 | PubMed |
| 36973270 | Cross-diagnostic determinants of cognitive functioning: the muscarinic cholinergic receptor as a model system. | Transl Psychiatry | 2023 | https://conductscience.org/library/papers/36973270 | PubMed |
| 36879885 | AI-DrugNet: A network-based deep learning model for drug repurposing and combination therapy in neurological disorders. | Comput Struct Biotechnol J | 2023 | https://conductscience.org/library/papers/36879885 | PubMed |
| 36552984 | A Review of the Recent Advances in Alzheimer's Disease Research and the Utilization of Network Biology Approaches for Prioritizing Diagnostics and Therapeutics. | Diagnostics (Basel) | 2022 | https://conductscience.org/library/papers/36552984 | PubMed |
| 36012193 | New Possibilities in the Therapeutic Approach to Alzheimer's Disease. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36012193 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ACHE | 43 | PubTator's text mining | https://conductscience.org/library/genes/43 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8915035
GET https://conductscience.org/api/papers/v1/8915035/cited_by?page=2